Sponsored diagnostic testing programs for Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
VLCAD Deficiency is a rare inherited fatty-acid oxidation disorder that impairs the body’s ability to convert long-chain fats into usable energy, particularly during fasting or illness. Symptoms can include hypoglycemia, muscle weakness, rhabdomyolysis, cardiomyopathy, or liver dysfunction, with severity ranging from mild exercise-induced episodes to life-threatening metabolic crises in infancy.
1 program found for Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
The Invitae Unlock™ Cardiomyopathy & Arrhythmia program offers no-charge genetic testing for U.S. patients with suspected inherited cardiomyopathy or arrhythmia. The comprehensive panel supports diagnostic clarification, risk assessment, and family variant identification. Eligible patients may access testing at no cost when ordered by a qualified healthcare provider.
